TY - CONF
T1 - 55: Intravesical electrical stimulation (IVES) treatment for overactive bladder syndrome (OAB): A pilot study
AU - Yune, J.J.
AU - Shen, J.
AU - Hardesty, J.
AU - Kim, J.
AU - Siddighi, S.
PY - 2016/4
Y1 - 2016/4
N2 - Objectives: To assess the efficacy of Intravesical Electrical Stimulation (IVES) with a novel technique in a pilot study on women with urinary urgency and/or urgency urinary incontinence. Methods: After the study was approved by the Loma Linda University Medical Center Institutional Review Board, IVES was performed in women with OAB-wet (episodes of urinary urgency incontinence ≥3 in 3-day voiding diary) or OAB-dry (frequency ≥ 8/day or nocturia ≥ 2/night) who failed prior medical treatment. Patients with neurogenic bladder, stress predominant urinary incontinence, or other recent OAB treatments were excluded. An 8 Fr detruset™ IVES catheter (EMED, El Dorado Hills, CA) was used to deliver electrical stimulation into the bladder. Each therapy session lasts 20 minutes and all subjects received biweekly treatment for 4 weeks. The primary outcome was PGI-I (Patient Global Impression of Improvement, 1-7 with 1 being the best) at 3 months after treatment. The secondary outcomes included visual analog scale (VAS,0-10 with 10 being the worst) of symptom severity, validated standard questionnaires (OAB-q SF, PFDI, and PFIQ), reduction in urinary frequency and urgency incontinence episodes (average per day) in 3-day voiding diary, and adverse effects. Comparative statistics were performed using paired t-test or non parametric Wilcoxon test with a p value of
AB - Objectives: To assess the efficacy of Intravesical Electrical Stimulation (IVES) with a novel technique in a pilot study on women with urinary urgency and/or urgency urinary incontinence. Methods: After the study was approved by the Loma Linda University Medical Center Institutional Review Board, IVES was performed in women with OAB-wet (episodes of urinary urgency incontinence ≥3 in 3-day voiding diary) or OAB-dry (frequency ≥ 8/day or nocturia ≥ 2/night) who failed prior medical treatment. Patients with neurogenic bladder, stress predominant urinary incontinence, or other recent OAB treatments were excluded. An 8 Fr detruset™ IVES catheter (EMED, El Dorado Hills, CA) was used to deliver electrical stimulation into the bladder. Each therapy session lasts 20 minutes and all subjects received biweekly treatment for 4 weeks. The primary outcome was PGI-I (Patient Global Impression of Improvement, 1-7 with 1 being the best) at 3 months after treatment. The secondary outcomes included visual analog scale (VAS,0-10 with 10 being the worst) of symptom severity, validated standard questionnaires (OAB-q SF, PFDI, and PFIQ), reduction in urinary frequency and urgency incontinence episodes (average per day) in 3-day voiding diary, and adverse effects. Comparative statistics were performed using paired t-test or non parametric Wilcoxon test with a p value of
UR - https://www.sciencedirect.com/science/article/pii/S0002937816000880
UR - https://www.mendeley.com/catalogue/3c70dd78-95b5-34ef-93ac-5fb4ea718360/
U2 - 10.1016/j.ajog.2016.01.086
DO - 10.1016/j.ajog.2016.01.086
M3 - Poster
SP - S496
ER -